Drug Profile
ABT 384
Alternative Names: ABT-384Latest Information Update: 28 Jul 2015
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Class Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease; Neurological disorders